These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1809073)

  • 1. HBV and HIV serological markers: the National External Quality Assessment Scheme in France.
    Goguel AF
    Ann Ist Super Sanita; 1991; 27(3):511-5. PubMed ID: 1809073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a western blot system (DAVIH-BLOT) for the confirmation of HIV-1 antibodies].
    Cruz Sui O; Pérez Guevara MT; Izquierdo Márquez M; Lobaina Batelemy L; Ruibal Brunet I; Silva Cabrera E
    Rev Cubana Med Trop; 1997; 49(1):28-31. PubMed ID: 9685957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroepidemiology for the hepatitis B virus (HBV) in pregnant women/parturients and its transmission to newborns in Goiânia, GO].
    Cardosa D das D; de Faria EL; de Azevedo MS; Queiroz DA; Martins RM; de Souza TT; Daher RR; Martelli CM
    Rev Soc Bras Med Trop; 1996; 29(4):349-53. PubMed ID: 8768583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of National Quality Control Reference Panels and Requirements for Hepatitis B diagnosis reagents in China.
    Wu S; Su T; Lin J; Chen Y; Wang Y; Zhou C; Xu Q; Li H
    Biologicals; 1993 Sep; 21(3):193-6. PubMed ID: 8117432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera.
    Ollier L; Laffont C; Kechkekian A; Doglio A; Giordanengo V
    J Virol Methods; 2008 Dec; 154(1-2):206-9. PubMed ID: 18848582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoassay external quality assessment in Italy: HBsAg and anti-HBs tests.
    Pizzocolo G; Malvano R; Pilloton E; Signorini C; Zanetti A; Albertini A
    Ann Ist Super Sanita; 1991; 27(3):487-93. PubMed ID: 1809069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serology study for HBV and HIV-1 in a cohort of parenteral drug addicts].
    Mauri R; Fumagalli S; Durello R
    Minerva Med; 1991 Nov; 82(11):771-3. PubMed ID: 1766580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
    J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA).
    Tsitsilonis OE; Thrasyvoulides A; Balafas A; Voutsas JF; Papamichail M; Lymberi P
    J Pharm Biomed Anal; 2004 Mar; 34(4):811-22. PubMed ID: 15019059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ADVIA Centaur infectious disease assays: a technical review.
    Dwyer R
    J Clin Virol; 2004 Apr; 30 Suppl 1():S1-5. PubMed ID: 15062760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.